[Remote] Senior Clinical Informatics Sales Specialist, South at Illumina

Washington, District of Columbia, United States

Illumina Logo
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Healthcare, Biotechnology, Genomics, Clinical Research, Clinical DiagnosticsIndustries

Skills

Key technologies and capabilities for this role

GenomicsHealthcare InformaticsNext Generation Sequencing (NGS)Genomic Data AnalysisClinical ResearchClinical TestingSalesCloud-based Enterprise PlatformsData AnalysisData Interpretation

Questions & Answers

Common questions about this position

What is the employment type for this position?

This is a full-time position.

Is this role remote or does it require travel in the South region?

This information is not specified in the job description.

What key expertise areas are required for the Senior Clinical Informatics Sales Specialist?

Key expertise includes data visualization, data science with AI and Machine Learning, cloud-based workflows and pipelines, Laboratory Information Management Systems (LIMS), and analysis/annotation/interpretation/reporting from NGS testing in clinical environments, plus oncology research and testing data analysis.

What is the company culture like at Illumina?

Illumina fosters a culture where every person in every role can make a difference, surrounded by extraordinary people, inspiring leaders, and world-changing projects, enabling employees to do more and become more than they thought possible while contributing to health equity through genomic technology.

What makes a strong candidate for this Senior Informatics Sales Specialist role?

Strong candidates have strong genomics, healthcare, and informatics technical knowledge, with expertise in clinical data analysis areas like NGS, AI/ML, cloud workflows, and LIMS, plus the ability to engage C-level executives, lab directors, and IT leaders to drive sales growth.

Illumina

Supports genomics startups through funding and resources

About Illumina

Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.

San Diego, CaliforniaHeadquarters
1998Year Founded
$27.2MTotal Funding
IPOCompany Stage
Venture Capital, BiotechnologyIndustries
5,001-10,000Employees

Risks

Over-reliance on NVIDIA's AI technology may limit flexibility in AI solution adoption.
Standardizing proteomics data across platforms could challenge Illumina's data reliability.
Single-flow-cell NovaSeq X System might cannibalize sales of higher-end models.

Differentiation

Illumina leads in genomic sequencing with advanced AI integration and multiomic data analysis.
The company offers innovative array-based solutions for DNA, RNA, and protein analysis.
Illumina's global expansion includes a new Global Capability Center in Bengaluru.

Upsides

Collaboration with NVIDIA enhances drug discovery and clinical development through AI integration.
Pilot proteomics program with UK Biobank aims to generate crucial reference datasets.
Single-cell sequencing kits make high-throughput sequencing accessible to smaller labs.

Land your dream remote job 3x faster with AI